US4100274A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Polypeptide
Assignee: Imperial Chemical Industries Ltd
•
Filing: 1977-04-22
•
Granted: 1978-07-11
•
Expires: 1997-04-22
Abstract
Abstract The disclosure relates to novel luliberin analogues which possess luliberin agonist activity, to processes for their manufacture and to compositions containing them. Typical of the peptides disclosed is <IMAGE> in which A is D-Phe, D-Tyr(Me) or D-Ser(But).
Inventors
- 👤 Anand Swaroop Dutta
- 👤 Barrington John Albert Furr
- 👤 Michael Brian Giles
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 16:13
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06086; C07K5/06095; A; A61; A61P; A61P15/00; C07K7/00; C07K7/04; C07K7/23; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/13
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
50 words
A polypeptide of the formula: ##STR8## in which A is selected from the group consisting of D-Tyr(Me), D-Ser(Bu t ) and D-Phe, B is selected from the group consisting of Leu or MeLeu, E is Azgly and F is an amino radical, and the pharmaceutically- and veterinarily-acceptable acid-addition salts thereof.
Claim 2
Dependent Claim
50 words
A polypeptide of the formula: ##STR8## in which A is selected from the group consisting of D-Tyr(Me), D-Ser(Bu t ) and D-Phe, B is selected from the group consisting of Leu or MeLeu, E is Azgly and F is an amino radical, and the pharmaceutically- and veterinarily-acceptable acid-addition salts thereof.
Claim 3
Dependent Claim
10 words
A polypeptide as claimed in claim 1 which is ##STR9##
Claim 4
Dependent Claim
10 words
A polypeptide as claimed in claim 1 which is ##STR10##
Claim 5
Dependent Claim
10 words
A polypeptide as claimed in claim 1 which is ##STR11##
Claim 6
Dependent Claim
35 words
A pharmaceutical or veterinary composition comprising as active ingredient an effective amount of a polypeptide as claimed in claim 1 in association with a major amount of a nontoxic pharmaceutically- or veterinarily-acceptible diluent or carrier.
Claim 7
Dependent Claim
25 words
A method of controlling and/or improving reproduction in warm-blooded animals which comprises administration of an effective amount of a polypeptide as claimed in claim 1.
References Cited (Backward Citations)
US3914412A
Cited
US4005063A
Cited
US3901872A
Cited
US4010149A
Cited
US3896104A
Cited
US4024248A
Cited
US3971737A
Cited
US4010125A
Cited
US4018726A
Cited
US3992530A
Cited
US4024121A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-07-10 | 1982-01-09 | 1982-07-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-07-10 | 1986-01-09 | 1986-07-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-07-10 | 1990-01-09 | 1990-07-11 | $7700.00 | Window Closed / Lapsed |